• WIP1/PPM1D, p38 MAPK, and Pyroptosis in Septic AKI

  2026-09-11

  The reference study identifies WIP1/PPM1D as a restraint on p38 MAPK-driven renal tubular pyroptosis during sepsis-associated acute kidney injury. Using single-cell data, human kidney samples, LPS injury models, and pharmacological inhibition with CCT007093, it connects elevated WIP1 with a p38-dependent inflammatory cell-death program.

• Verapamil Targets Txnip in Osteoporosis Research

  2026-09-11

  Cao et al. identify TXNIP variation as associated with osteoporosis-related bone mineral density and show that verapamil reduces ovariectomy-associated bone loss in mice. The study connects ChREBP-dependent TXNIP regulation with coordinated effects on osteoclast and osteoblast pathways, providing a preclinical rationale for investigating drug repurposing in postmenopausal osteoporosis.

• Antimycins as ATP-Citrate Lyase Inhibitors

  2026-09-10

  The reference study established that antimycin-class antibiotics from a Streptomyces species inhibit ATP-citrate lyase, connecting a historically known respiratory-chain inhibitor class with cytoplasmic acetyl-CoA production. Its fermentation, chromatographic, spectroscopic, and enzyme-assay workflow provides a useful framework for studying how antimycin congeners affect lipid precursor metabolism while recognizing their potential mitochondrial confounding activity.

• gamma-Glu-Cys (γ-Glu-Cys): Lab Protocol Guide

  2026-09-10

  This guide explains how to use gamma-Glu-Cys (γ-Glu-Cys) as a defined substrate and glutathione biosynthesis intermediate in enzyme, peptide, and plant-related workflows. It covers preparation, storage, QC, and assay controls while limiting interpretation to research use; the product is not intended for diagnostic, therapeutic, or medical applications.

• Asymmetric HflK/C Controls FtsH Proteolysis

  2026-09-09

  The reference study shows that native HflK/C does not form a uniformly closed cage around FtsH, but instead adopts an asymmetric nautilus-like assembly with an entryway for membrane proteins. Cryo-EM, proteomic degradation assays, and lipid-scrambling measurements connect this architecture to substrate access, membrane remodeling, and enhanced degradation of selected membrane-embedded proteins.

• AZD0156: Designing Smarter ATM Inhibition Assays

  2026-09-09

  AZD0156 is a selective ATM kinase inhibitor for investigating DNA damage response signaling, repair dependence, and combination effects. This guide translates ovarian cancer evidence into practical assay-design decisions for rigorous cancer therapy research.

• gamma-Glu-Cys: Designing Better Glutathione Assays

  2026-09-08

  gamma-Glu-Cys is a defined intermediate for glutathione synthetase enzyme assay development and glutathione metabolism research. This article explains how its biochemical position, matrix effects, and handling requirements can improve assay interpretation across microbial and plant systems.

• c-Myc tag Peptide for Immunoassay Workflows

  2026-09-08

  Use a defined c-Myc tag competitor to test antibody specificity, optimize tagged-protein recovery, and separate epitope effects from biological conclusions. This workflow-focused guide connects peptide displacement assays with transcription-factor research while clarifying practical limits, formulation choices, and troubleshooting steps.

• Caspase-4 Colorimetric Assay Kit: A Mechanistic Guide

  2026-09-07

  Discover how the Caspase-4 Colorimetric Assay Kit converts LEVD-dependent enzyme activity into a quantitative readout for pyroptosis and inflammation studies. This guide also explains how to interpret caspase-4 data alongside emerging organelle-targeted cancer-cell models without confusing pathway correlation with causation.

• Methylprednisolone Sodium Succinate in Cell Assays

  2026-09-07

  Build reproducible inflammation, immune-cell trafficking, and tumor-cell response assays with a water-soluble synthetic corticosteroid. This guide connects concentration-aware experimental design with practical controls, troubleshooting, and a careful comparison to receptor-pharmacology lessons from palonosetron research.

• EZ Cap EGFP mRNA 5-moUTP Workflow Guide

  2026-09-05

  Use EZ Cap EGFP mRNA 5-moUTP as a bright, stable reporter for cell transfection, LNP biodistribution, translation benchmarking, and fluorescent imaging. Its Cap1 structure, 5-methoxyuridine, and optimized poly(A) tail help separate delivery performance from avoidable RNA instability and innate immune effects.

• 3X FLAG Peptide: From Tagging to Translation

  2026-09-04

  A thought-leadership perspective on how the 3X (DYKDDDDK) Peptide can strengthen recombinant protein workflows, from affinity purification and immunodetection to structural biology, while helping translational researchers build more auditable mechanistic evidence.

• BOP Reagent for Prodrug Peptide Synthesis

  2026-09-04

  BOP reagent streamlines carboxyl group activation for direct amide bond formation, phenyl ester preparation, and linker construction in advanced peptide and prodrug workflows. This guide connects practical coupling decisions with a carrier-free triterpene prodrug strategy for oral squamous cell carcinoma research while clearly separating reported findings from recommended method development.

• Triterpene Prodrug Strategy for Targeted OSCC Therapy

  2026-09-03

  This study develops a carrier-free, self-assembled triterpene prodrug that combines ROS-responsive release, glucose-transporter-associated uptake, and dual-agent cytotoxicity against oral squamous cell carcinoma. Its key contribution is a self-amplifying mechanism in which glycyrrhetinic acid increases oxidative stress, promoting further release of glycyrrhetinic acid and ginsenoside Rh2 while reducing reliance on an external nanocarrier.

• Methotrexate in Psoriasis Pathway Research

  2026-09-03

  Methotrexate is a folate antagonist whose effects on nucleotide metabolism, activated T cells, and inflammatory signaling make it a valuable psoriasis research comparator. This guide connects its intracellular pharmacology with the IL-17/IL-23 and PTGS2/NF-κB/AP-1 findings of a recent tanshinone IIA study to improve assay design.

8177 records 1/546 page Next 12345 下5页 Last page